PMID

Data

Article Title

Organization

Synthesis and mechanism of action of novel pyrimidinyl pyrazole derivatives possessing antiproliferative activity.

Daiichi Pharmaceutical

Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist.

Daiichi Pharmaceutical

Cycloalkanediamine derivatives as novel blood coagulation factor Xa inhibitors.

Daiichi Pharmaceutical

Synthesis and conformational analysis of a non-amidine factor Xa inhibitor that incorporates 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine as S4 binding element.

Daiichi Pharmaceutical

Orally active factor Xa inhibitors: 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine derivatives.

Daiichi Pharmaceutical

MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds.

Daiichi Pharmaceutical

Rational design and evaluation of new lead compound structures for selective betaARK1 inhibitors.

Daiichi Pharmaceutical

Dibasic (amidinoaryl)propanoic acid derivatives as novel blood coagulation factor Xa inhibitors.

Daiichi Pharmaceutical

Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position.

Daiichi Pharmaceutical

Isoindoline derivatives for use in the treatment of a viral infection

Viiv Healthcare

Antivirals against molluscum contagiosum virus

University of Pennsylvania